Use of botulinum toxin in the neurology clinic
- 12 October 2010
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Neurology
- Vol. 6 (11), 624-636
- https://doi.org/10.1038/nrneurol.2010.149
Abstract
Botulinum neurotoxin (BoNT) is an effective treatment for a wide range of conditions that are frequently seen in the neurology clinic. In this article, Lim and Seet provide an overview of the mechanisms of action of BoNT and its use in the treatment of conditions such as dystonia, spasticity, essential tremor, hemifacial spasm and headaches. Important practical considerations, such as the reconstitution of BoNT, dosing, and methods of administration, are also reviewed. Botulinum neurotoxin (BoNT) is an effective treatment for conditions associated with overactivity of glandular, smooth or skeletal muscle, and this toxin can also ameliorate certain painful conditions. Electromyography, endoscopy and imaging techniques such as ultrasonography and fluoroscopy have been used to increase the accuracy of BoNT injections. This Review assesses the mechanisms of action of BoNT, and examines the use of BoNT injections in numerous neurological conditions, including dystonia, spasticity, headaches and other painful disorders, hemifacial spasm, essential tremor, motor tics, hyperhidrosis, and sialorrhea and drooling. Important practical aspects, such as the reconstitution of BoNT, dosing, and methods of administration, are also addressed.Keywords
This publication has 122 references indexed in Scilit:
- Practice Parameter: Pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review)Neurology, 2010
- Migraine prophylaxis with botulinum toxin A is associated with perception of headacheToxicon, 2009
- The management of ticsMovement Disorders, 2009
- Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidenceJournal of Neural Transmission, 2009
- Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): [RETIRED]Neurology, 2008
- Sialorrhoea and Drooling in Patients with Parkinson’s DiseaseDrugs & Aging, 2008
- Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: A 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safetyJournal of the American Academy of Dermatology, 2007
- Exploding vs. imploding headache in migraine prophylaxis with Botulinum Toxin APain, 2006
- Botulinum toxin therapy of hemifacial spasm: comparing different therapeutic preparationsEuropean Journal of Neurology, 2006
- Botulinum toxin type A injections: Adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic casesJournal of the American Academy of Dermatology, 2005